utahmed.com (UTMD): Rentabilitas operasi

Utah Medical (UTMD) - logo korporat

High patent barriers and FDA certification support Utah Medical Products (UTMD) quotes, while the current operating margin is trending upward, with the 30.50 metric serving as the target level. Stable revenue is driven by the maturity of the business in obstetrics, and a focus on high-precision minimally invasive devices for women's health strengthens the company's financial resilience, confirming the effectiveness of its market strategy.

UTMD - Rasio bathi operasi Utah Medical Products, Inc. ing rentang 04.07.2022 - 20.11.2026

Rincian analitis lan laporan data perusahaan Utah Medical Products, Inc. (UTMD)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Produk merek utahmed.com

Investors must filter out random volatility to assess the real business efficiency of Utah Medical Products (UTMD). The absence of debt and strict adherence to FDA standards minimize the company's operational risks. By analyzing the operating profit before interest and taxes, you can see the portion of revenue remaining after covering all production costs. This metric measures internal profitability without accounting for financial leverage. The stability of this indicator confirms the high fundamental reliability of the model.

Pesaing utama

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|Margin dodolan operasi TKNO|Margin operasi monogramorthopedics.com|Margin dodolan operasi STSS (Sharps Technology, Inc.)|Rasio bathi operasi INFU|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi